
### [MONDO:0002082](http://purl.obolibrary.org/obo/MONDO_0002082)
**Label:** endocrine gland cancer

**Subclasses:** [MONDO:0017896](http://purl.obolibrary.org/obo/MONDO_0017896) (familial nonmedullary thyroid carcinoma), [MONDO:0016722](http://purl.obolibrary.org/obo/MONDO_0016722) (pineoblastoma), [MONDO:0018666](http://purl.obolibrary.org/obo/MONDO_0018666) (hepatoblastoma), [MONDO:0019954](http://purl.obolibrary.org/obo/MONDO_0019954) (pancreatic neuroendocrine tumor), [MONDO:0015285](http://purl.obolibrary.org/obo/MONDO_0015285) (Carney complex), [MONDO:0015066](http://purl.obolibrary.org/obo/MONDO_0015066) (neuroendocrine tumor of the appendix), [MONDO:0019003](http://purl.obolibrary.org/obo/MONDO_0019003) (multiple endocrine neoplasia type 2), [MONDO:0017895](http://purl.obolibrary.org/obo/MONDO_0017895) (familial papillary or follicular thyroid carcinoma), [MONDO:0015078](http://purl.obolibrary.org/obo/MONDO_0015078) (Gastroenteropancreatic endocrine tumor), [MONDO:0019496](http://purl.obolibrary.org/obo/MONDO_0019496) (neuroendocrine tumor), [MONDO:0019087](http://purl.obolibrary.org/obo/MONDO_0019087) (cholangiocarcinoma), [MONDO:0015063](http://purl.obolibrary.org/obo/MONDO_0015063) (duodenal neuroendocrine tumor), [MONDO:0015075](http://purl.obolibrary.org/obo/MONDO_0015075) (thyroid carcinoma (disease)), [MONDO:0017582](http://purl.obolibrary.org/obo/MONDO_0017582) (pituitary carcinoma (disease)), [MONDO:0008567](http://purl.obolibrary.org/obo/MONDO_0008567) (thyroid cancer, nonmedullary, 1), [MONDO:0015081](http://purl.obolibrary.org/obo/MONDO_0015081) (neuroendocrine tumor with other location), [MONDO:0006456](http://purl.obolibrary.org/obo/MONDO_0006456) (thymoma (disease)), [MONDO:0007256](http://purl.obolibrary.org/obo/MONDO_0007256) (hepatocellular carcinoma), [MONDO:0006451](http://purl.obolibrary.org/obo/MONDO_0006451) (thymic carcinoma), [MONDO:0015447](http://purl.obolibrary.org/obo/MONDO_0015447) (differentiated thyroid carcinoma), 

**Corr. equiv. classes:** [Orphanet:100101](http://www.orpha.net/ORDO/Orphanet_100101), [Orphanet:100079](http://www.orpha.net/ORDO/Orphanet_100079), [Orphanet:146](http://www.orpha.net/ORDO/Orphanet_146), [Orphanet:97253](http://www.orpha.net/ORDO/Orphanet_97253), [Orphanet:100076](http://www.orpha.net/ORDO/Orphanet_100076), [Orphanet:100088](http://www.orpha.net/ORDO/Orphanet_100088), [Orphanet:251909](http://www.orpha.net/ORDO/Orphanet_251909), [OMIM:188550](http://purl.obolibrary.org/obo/OMIM_188550), [Orphanet:300385](http://www.orpha.net/ORDO/Orphanet_300385), [OMIM:114550](http://purl.obolibrary.org/obo/OMIM_114550), [Orphanet:88673](http://www.orpha.net/ORDO/Orphanet_88673), [Orphanet:70567](http://www.orpha.net/ORDO/Orphanet_70567), [Orphanet:319494](http://www.orpha.net/ORDO/Orphanet_319494), [Orphanet:449](http://www.orpha.net/ORDO/Orphanet_449), [Orphanet:100092](http://www.orpha.net/ORDO/Orphanet_100092), [Orphanet:877](http://www.orpha.net/ORDO/Orphanet_877), [Orphanet:99867](http://www.orpha.net/ORDO/Orphanet_99867), [Orphanet:99868](http://www.orpha.net/ORDO/Orphanet_99868), [Orphanet:319487](http://www.orpha.net/ORDO/Orphanet_319487), [Orphanet:1359](http://www.orpha.net/ORDO/Orphanet_1359), [Orphanet:653](http://www.orpha.net/ORDO/Orphanet_653), 

**Class expressions from DL-Learner:**

- [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) and (not ([HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality))) 41.01%
- [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) and (not ([HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders))) 41.01%
- [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) and (not ([HP:0000929](http://purl.obolibrary.org/obo/HP_0000929) (Abnormality of the skull))) 41.01%
- [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) and (not ([HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability))) 39.82%
- [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) and (not ([HP:0001999](http://purl.obolibrary.org/obo/HP_0001999) (Abnormal facial shape))) 39.29%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 39.17%
- [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) and (not ([HP:0012640](http://purl.obolibrary.org/obo/HP_0012640) (Abnormality of intracranial pressure))) 37.86%
- [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) and (not ([HP:0002516](http://purl.obolibrary.org/obo/HP_0002516) (Increased intracranial pressure))) 37.86%
- [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) and (not ([HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia))) 37.86%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 36.87%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 33.34%
- Thing 33.33%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 33.33%
- [HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system) 30.90%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 26.62%


